NCT02566265View on ClinicalTrials.gov

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

June 30, 2018

Conditions
InfluenzaMultiple MyelomaWaldenstrom's MacroglobulinemiaPlasma Cell DisordersMGUS
Interventions
BIOLOGICAL

Fluzone High Dose Vaccine

BIOLOGICAL

Standard of care/Placebo

Trial Locations (1)

Unknown

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02566265 - Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients | Biotech Hunter | Biotech Hunter